VEGFA and age-related macular degeneration: AMD eyes were treated with anti-VEGF (mean number of injections prior to MaH = 8.8 ± 9.5; median = 4) following mostly a Pro Re Nata (PRN) regime (Supplementary Table S1 and Table 3).